Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
NIHR HSC. Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2015
Final publication URL
Subject indexing assigned by CRD
Antiviral Agents; Genotype; Hepatitis C, Chronics; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins; Uridine Monophosphate; Viral Nonstructural Proteins
Country of organisation
An English language summary is available.
Address for correspondence
NIHR Horizon Scanning Centre, School of Health&Population Sciences, University of Birmingham, Public Health building, Edgbaston, Birmingham, B15 2TT. Tel: +44 121 414 7831 Email: email@example.com
Date abstract record published
Health Technology Assessment (HTA) database
Copyright © 2020 NIHR Horizon Scanning Centre (NIHR HSC)
Message for HTA database users